The COVID-19 crisis has seen an unprecedented
international effort to develop technologies to diagnose, prevent
and treat this deadly disease.
Alongside companies with existing COVID-19 relevant
technologies, many businesses are transforming their operations to
support these efforts. This presents challenges for owners of
existing relevant intellectual property (IP) whose IP rights are
now being infringed, and for those rapidly developing technologies
or manufacturing support, who may be knowingly or inadvertently
infringing others' IP.
This article explores these pressing IP issues, and looks at how
they can be resolved.
Existing IP Owners
Many of the products now being manufactured in substantial
quantities to meet the demand will already be protected by existing
IP. This IP may be infringed by companies who do not traditionally
operate in the sector, but have now adapted and turned to
manufacturing products needed to meet urgent requirements,
including